seri
novel
bear
lipophil
adamantyl
substitu
posit
synthes
major
show
modest
activ
wherea
endow
remark
antivir
potenc
ec
mm
new
seri
compound
adamantyl
moieti
thiazolidinon
ring
show
good
modest
activ
ec
mm
also
pronounc
cytostat
activ
exampl
show
ec
mm
effect
concentr
mm
respect
xray
studi
quantum
chemic
calcul
reveal
antihiv
activ
compound
strongli
depend
dipol
moment
conform
thiazolidinon
previous
report
sever
show
modest
activ
case
racem
ae
remark
antivir
potenc
ec
mm
observ
presenc
adamantan
moieti
play
import
role
eventu
antivir
activ
compound
compound
behav
typic
nonnucleosid
revers
transcriptas
rt
inhibitor
nnrti
noncompetit
inhibit
rt
respect
nucleotid
substrat
k
mm
k
k
separ
enantiom
via
diastereoisomer
salt
perform
thiazolidinon
xray
studi
enabl
us
ascrib
r
configur
furthermor
found
isom
shown
fig
predominantli
respons
potent
activ
ec
valu
mm
levo
isom
less
activ
find
confirm
gener
rule
one
defin
nnrti
enantiom
inhibit
rt
one
usual
markedli
less
potent
even
inact
moreov
found
thiazolidinon
investig
show
antivir
activ
similar
pharmacophor
ie
amid
nitrogen
atom
connect
via
one
two
three
carbon
chain
nitrogen
atom
substitut
amin
pyridin
prompt
observ
decid
extend
group
novel
nonnucleosid
revers
transcriptas
inhibitor
bear
bulki
lipophil
adamantyl
entiti
design
synthes
three
seri
thiazolidinon
deriv
compound
repres
addit
present
previous
compound
thiazolidinon
fluorin
chlorin
substitut
phenyl
ring
instead
adamantan
moieti
consist
adamantyl
group
connect
via
methylen
ethylen
bridg
nitrogen
atom
thiazolidinon
ring
mention
haloaromat
substitu
present
activ
thiazolidinon
describ
monfort
et
al
mani
thiazolidinon
pyridyl
pyrimidyl
group
nsubstitu
result
obtain
author
show
compound
pyrimidin
nucleu
mostli
time
less
activ
activ
thiazolidinon
contain
meo
dihalo
substitu
attach
aromat
ring
methyl
group
pyridyl
nucleu
compound
prepar
accord
scheme
shown
fig
onepot
twostep
methodolog
describ
previous
start
reagent
synthesi
titl
thiazolidinon
respect
aldehyd
prepar
swern
oxid
adamantanemethanol
gener
pathway
synthes
present
scheme
given
fig
compound
obtain
commerci
avail
well
amin
compon
use
reagent
synthes
respect
adamantan
alcohol
mitsunobu
condens
phthalimid
consecut
hydrolysi
imid
gabriel
method
gener
pathway
obtain
present
fig
structur
formula
obtain
compound
given
tabl
structur
puriti
novel
compound
confirm
element
analysi
nmr
ftir
spectroscopi
well
chromatograph
method
case
perform
xray
studi
structur
conform
determin
obtain
thiazolidinon
compound
evalu
inhibitori
activ
iii
b
rod
induc
cytopath
cem
cell
cultur
result
display
tabl
parent
pyridin
lead
deriv
nonnucleosid
rt
inhibitor
nevirapin
nucleosid
rt
inhibitor
ddi
didanosin
includ
refer
compound
tabl
compound
belong
group
activ
agent
describ
previou
public
ie
ec
mm
structur
differ
compound
compound
consist
replac
nucleu
nsubstitu
thiazolidinon
ec
mm
bear
group
wtwo
time
less
potent
parent
refer
compound
antivir
potenc
select
close
clinicallyus
compound
nevirapin
replac
ec
mm
result
reduct
antivir
potenc
similar
tendenc
observ
previou
work
thiazolidinon
contain
thu
connect
heterocycl
seem
crucial
activ
also
strike
notic
minor
modif
inclus
methyl
andor
chloro
group
pyrimidin
ring
may
dramat
effect
eventu
antivir
activ
compound
tabl
second
group
compound
studi
belong
thiazolidinon
contrast
compound
contain
adamantylmethylen
instead
adamantyl
substitu
connect
heterocycl
ring
littl
modif
structur
invari
caus
reduct
antivir
activ
ec
mm
exampl
methylen
bridg
insert
heterocycl
ring
give
compound
ec
mm
reduct
potenc
observ
tendenc
also
evid
compar
instanc
ec
mm
complet
inact
respect
agent
report
previous
data
point
crucial
rather
fix
interact
point
adamantan
part
inhibitori
molecul
rt
enzym
properti
often
observ
mani
nonnucleosid
revers
transcriptas
inhibitor
interest
compound
ring
posit
show
activ
wherea
substitu
lost
antivir
properti
third
seri
compound
structur
entir
new
compound
show
good
modest
activ
ec
mm
also
pronounc
cytostat
activ
exampl
show
ec
mm
effect
concentr
mm
respect
seri
effect
alkylen
bridg
length
unambigu
sinc
ethyl
result
pronounc
activ
methyl
compound
compar
wherea
presenc
methyl
result
activ
agent
ethyl
compound
compar
also
notic
thiazolidinon
exhibit
certain
antivir
activ
ec
mm
current
unclear
whether
activ
reflect
specif
antivir
effect
rather
like
toxic
effect
compound
inde
evid
data
tabl
antivir
activ
compound
concentr
close
cytostat
concentr
cc
obtain
mockinfect
cell
cultur
four
seri
well
r
enantiom
also
evalu
inhibitori
activ
recombin
rt
show
pronounc
inhibit
rtcatalys
reaction
appreci
activ
rt
point
select
compound
seem
behav
nnrti
ic
test
compound
present
tabl
moreov
fair
correl
log
ic
rt
log
ec
r
would
obviou
synthes
also
deriv
without
methylen
group
nitrogen
atom
thiazolidin
ring
see
fig
unfortun
react
aromat
aldehyd
aminogroup
attach
via
tertiari
carbon
atom
adamantyl
skeleton
complet
inact
condens
aromat
aldehyd
obtain
expect
compound
imposs
compound
also
evalu
broad
varieti
dna
rna
virus
ie
herp
simplex
viru
type
type
vaccinia
viru
vesicular
stomat
viru
vsv
b
mdck
cell
cultur
none
compound
show
appreci
activ
subtox
concentr
sinc
adamantadin
heterocycl
rimantadin
analogu
recent
obtain
display
antiinfluenza
viru
activ
inact
adamantanyl
deriv
viru
like
due
bulki
moieti
link
adamantan
xray
measur
possibl
highqual
monocryst
proper
dimens
thiazolidinon
three
compound
seri
could
form
suitabl
crystal
major
compound
obtain
finecrystallin
amorph
liquid
better
understand
differ
antivir
activ
studi
compound
perform
xray
structur
studi
quantum
chemic
calcul
number
select
compound
ie
calcul
molecular
geometri
shown
fig
plot
reveal
butterflylik
conform
typic
nnrti
geometri
remain
three
structur
visual
fig
togeth
result
potenti
densiti
calcul
quantum
chemic
calcul
perform
use
program
singl
point
rhf
calcul
use
basi
set
perform
molecular
structur
taken
crystallograph
studi
result
serv
basi
potenti
densiti
dipol
moment
calcul
given
structur
tabl
volum
surfac
well
dipol
moment
calcul
thiazolidinon
present
comparison
calcul
also
perform
result
shown
graphic
fig
molecul
topolog
nondistinguish
seen
valu
volum
surfac
molecul
slightli
smaller
molecul
see
tabl
opinion
dipol
moment
might
treat
global
measur
electr
properti
molecul
fig
one
see
four
molecul
distinct
electroneg
region
shown
red
yellow
electroposit
one
shown
blue
green
molecul
upper
row
site
nitrogen
atom
henc
neg
potenti
one
also
see
thiazolidinon
fragment
molecul
coplanar
aromat
ring
upperrow
molecul
fact
might
correl
antihiv
activ
compound
list
tabl
compound
belong
complet
differ
class
molecul
topolog
point
view
similar
other
similar
volum
surfac
molecul
dipol
moment
similar
crystal
structur
nt
studi
howev
similar
activ
previous
studi
molecul
essenti
compar
valu
dipol
moment
electrostat
potenti
distribut
molecul
therefor
perform
simpl
quantummechan
calcul
evalu
valu
deriv
tabl
fig
compound
higher
dipol
moment
twist
aromat
ring
relat
heterocycl
one
show
antihiv
activ
wherea
remain
thiazolidinon
complet
inact
commerci
reagent
solvent
use
without
purif
reaction
monitor
gc
xray
measur
perform
oxford
diffract
xcalibur
kaxi
diffractomet
rubi
ccddetector
cu
ka
characterist
radiat
use
collect
data
obtain
way
describ
previou
public
compound
synthes
accord
method
publish
aldehyd
crude
product
swern
reaction
purifi
flashcolumn
chromatographi
use
chcl
eluent
colourless
oil
ftir
ch
cl
cm
adamantanemethanol
g
mmol
adamantaneethanol
g
mmol
dissolv
ml
dri
thf
next
phthalimid
g
mmol
triphenylphosphin
g
mmol
diethyl
azodicarboxyl
g
mmol
ad
solut
mixtur
stir
h
room
temperatur
thf
care
evapor
residu
crystal
methanol
white
crystal
imid
g
mp
c
hydrochlorid
g
mmol
phthalimid
g
mmol
heat
h
ml
dri
ethanol
hydrazin
hydrat
g
mmol
ml
hcl
ad
mixtur
reflux
min
white
deposit
filter
filtrat
concentr
filter
solut
extract
three
portion
diethyl
ether
ml
organ
layer
dri
mgso
ether
evapor
next
colourless
oil
hcl
methanol
ml
ad
solvent
evapor
crude
product
crystal
dri
methanol
white
crystal
hydrochlorid
g
mp
c
white
crystal
hydrochlorid
g
mp
c
obtain
respect
synthes
use
method
describ
mixtur
appropri
aldehyd
mmol
respect
amin
mmol
reflux
h
toluen
ml
simultan
azeotrop
remov
water
mercaptoacet
acid
ml
mmol
ad
mixtur
reflux
h
cool
solut
wash
two
time
satur
solut
nahco
brine
mixtur
dri
magnesium
sulphat
solvent
evapor
residu
oil
solid
purifi
flashcolumn
chromatographi
use
chloroform
chloroform
methanol
mixtur
eluent
xray
studi
singl
crystal
obtain
recrystal
respect
thiazolidinon
heptan
reaction
perform
h
white
crystal
obtain
mg
mp
c
h
nmr
reaction
perform
h
white
crystal
obtain
mg
mp
c
reaction
perform
h
white
crystal
obtain
mg
mp
c
reaction
perform
h
white
crystal
obtain
mg
mp
c
reaction
perform
h
white
crystal
obtain
mg
mp
c
reaction
perform
h
white
crystal
obtain
mg
mp
c
reaction
perform
h
white
crystal
obtain
mg
mp
c
reaction
perform
h
colourless
oil
obtain
mg
data
collect
use
cu
ka
radiat
mount
center
singl
crystal
diffractomet
reflect
collect
structur
solv
direct
method
program
refin
f
use
softwar
detail
structur
data
deposit
ccdc
number
respect
human
immunodefici
viru
type
iii
b
obtain
dr
rc
gallo
nation
cancer
institut
bethesda
md
rod
provid
dr
l
montagni
pasteur
institut
pari
franc
cem
cell
per
millilitr
infect
iii
b
rod
ccid
cell
cultur
infect
dose
per
millilitr
cell
suspens
ml
infect
cell
suspens
transfer
microlitr
plate
well
mix
ml
appropri
dilut
test
compound
giant
cell
format
record
microscop
hivinfect
cell
cultur
day
effect
concentr
ec
test
compound
defin
compound
concentr
requir
inhibit
virusinduc
cytopath
cem
cytostat
concentr
cc
defin
compound
concentr
requir
inhibit
mockinfect
cem
cell
prolifer
sourc
revers
transcriptas
use
recombin
hiv
rt
deriv
iiib
rod
construct
prepar
describ
rt
assay
contain
total
reaction
mixtur
volum
ml
mm
trisehcl
ph
mm
dithiothreitol
mm
glutathion
mm
edta
mm
kcl
mm
mgcl
mg
bovin
serum
albumin
label
substrat
h
dgtp
mci
specif
radioact
cimmol
mm
moravek
biochem
brea
ca
fix
concentr
templateprim
poli
c
oligo
dg
mm
triton
ml
inhibitor
variou
concentr
ml
rt
prepar
reaction
mixtur
incub
c
min
time
ml
yeast
rna
mgml
ml
trichloroacet
acid
vv
satur
na
p
hcl
ad
solut
kept
ice
min
acidinsolubl
materi
wash
analyz
radioact
ic
test
compound
determin
compound
concentr
inhibit
hiv
rt
activ
present
public
well
previou
paper
perform
synthesi
two
new
subclass
nnrti
first
one
includ
adamantyl
moieti
attach
directli
via
methylen
ethylen
bridg
thiazolidinon
ring
compound
adamantyl
group
heterocycl
ring
belong
second
subclass
nnrti
compound
bear
nucleu
show
highest
antihiv
activ
ec
mm
respect
xray
measur
reveal
agent
exist
butterfli
conform
common
mani
nnrti
quantum
chemic
calcul
reveal
also
antihiv
activ
compound
strongli
depend
dipol
moment
